March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Get information on several cancers that are common in HIV+ people: Kaposi's sarcoma, lymphoma, and cervical, liver, anal, and lung cancers.
Diarrhea is one of the most common problems for HIV+ people. Learn how it affects your body and what you can do to prevent and treat it.
Talking with children about HIV can be tough but important. Get some tips on how to share age appropriate information about HIV with kids.